Race and medicine.
Holden
Constance
C
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D044466:Asian People / Q000235:genetics; D044383:Black People / Q000235:genetics; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology / Q000235:genetics*; D002986:Clinical Trials as Topic; D005006:Ethnicity / Q000235:genetics; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000235:genetics; D007194:India / Q000208:ethnology; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D044469:Racial Groups / Q000235:genetics*; D012307:Risk Factors; D044465:White People / Q000235:genetics
D000319:Adrenergic beta-Antagonists; D000924:Anticholesteremic Agents; D004364:Pharmaceutical Preparations